# B Group, Inc.: Form 13F holdings

An institutional investment manager in DALLAS, TX. SEC CIK 2043476.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $213.0m
- Positions: 19 (19 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/2043476/000142050626001657/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| INVESCO QQQ TR | PUT | $36.8m | 17.3% | 50,000 | Put | New +50,000 |
| [ADMA BIOLOGICS INC (ADMA)](/companies/adma.md) | COM | $27.3m | 12.8% | 3,262,542 |  | Added +55,000 |
| [PALISADE BIO INC (PALI)](/companies/pali.md) | COM | $23.9m | 11.2% | 11,414,285 |  | Unchanged |
| [NRX PHARMACEUTICALS INC (NRXP)](/companies/nrxp.md) | COM NEW | $16.7m | 7.9% | 4,091,767 |  | Added +1,091,767 |
| [FAETH THERAPEUTICS INC (FTH)](/companies/fth.md) | COM NEW | $15.3m | 7.2% | 610,169 |  | New +610,169 |
| [TAYSHA GENE THERAPIES INC (TSHA)](/companies/tsha.md) | COM SHS | $12.3m | 5.8% | 1,800,556 |  | Unchanged |
| [PRAXIS PRECISION MEDICINES I (PRAX)](/companies/prax.md) | COM NEW | $11.1m | 5.2% | 33,237 |  | Unchanged |
| [CELLECTIS S A (CLLS)](/companies/clls.md) | SPON ADS | $9.8m | 4.6% | 3,281,501 |  | Unchanged |
| [ZAI LAB LTD (ZLAB)](/companies/zlab.md) | ADR | $8.6m | 4.0% | 450,646 |  | Unchanged |
| [STRUCTURE THERAPEUTICS INC (GPCR)](/companies/gpcr.md) | SPONSORED ADS | $7.5m | 3.5% | 140,000 |  | Added +12,500 |
| [ORUKA THERAPEUTICS INC (ORKA)](/companies/orka.md) | COM | $7.1m | 3.4% | 75,000 |  | Unchanged |
| [IOVANCE BIOTHERAPEUTICS INC (IOVA)](/companies/iova.md) | COM | $6.2m | 2.9% | 1,500,000 |  | Unchanged |
| [SPYRE THERAPEUTICS INC (SYRE)](/companies/syre.md) | COM NEW | $6.2m | 2.9% | 70,000 |  | Reduced −30,000 |
| [AURA BIOSCIENCES INC (AURA)](/companies/aura.md) | COM | $5.4m | 2.5% | 764,243 |  | Added +166,667 |
| [ASSEMBLY BIOSCIENCES INC (ASMB)](/companies/asmb.md) | COM NEW | $4.8m | 2.3% | 175,706 |  | Unchanged |
| [BRIGHT MINDS BIOSCIENCES INC (DRUG)](/companies/drug.md) | COM NEW | $4.7m | 2.2% | 67,500 |  | Unchanged |
| [ULTRAGENYX PHARMACEUTICAL IN (RARE)](/companies/rare.md) | COM | $4.5m | 2.1% | 135,000 |  | Unchanged |
| [SIGHT SCIENCES INC (SGHT)](/companies/sght.md) | COM | $3.7m | 1.7% | 970,000 |  | Unchanged |
| [FOGHORN THERAPEUTICS INC (FHTX)](/companies/fhtx.md) | COM | $976.0k | 0.5% | 200,000 |  | Added +98,000 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| APOGEE THERAPEUTICS INC | COM | $0 | 0.0% | 0 |  | Sold out −7,500 |
| [REPLIMUNE GROUP INC (REPL)](/companies/repl.md) | COM | $0 | 0.0% | 0 |  | Sold out −26,000 |
| SOLENO THERAPEUTICS INC | COM | $0 | 0.0% | 0 |  | Sold out −7,500 |

Source: SEC EDGAR, Form 13F-HR, accession 0001420506-26-001657. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.